Literature DB >> 12077314

Microbial subversion of the immune response.

P J Lachmann1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12077314      PMCID: PMC124270          DOI: 10.1073/pnas.132284499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  4 in total

1.  RETRACTED: Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans.

Authors:  K H Murthy; S A Smith; V K Ganesh; K W Judge; N Mullin; P N Barlow; C M Ogata; G J Kotwal
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

2.  Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.

Authors:  G J Kotwal; B Moss
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

3.  Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment.

Authors:  R F Tsuji; I Kawikova; R Ramabhadran; M Akahira-Azuma; D Taub; T E Hugli; C Gerard; P W Askenase
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

4.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

  4 in total
  14 in total

1.  PNAS policy on publication of sensitive material in the life sciences.

Authors:  Nicholas R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-15       Impact factor: 11.205

2.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).

Authors:  Robert J Boackle; Quang L Nguyen; Renata S Leite; Xiaofeng Yang; Jana Vesely
Journal:  Mol Immunol       Date:  2005-03-05       Impact factor: 4.407

Review 4.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

5.  Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).

Authors:  Jayati Mullick; Akhilesh K Singh; Yogesh Panse; Vivekanand Yadav; John Bernet; Arvind Sahu
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Dissection of functional sites in herpesvirus saimiri complement control protein homolog.

Authors:  Malik Johid Reza; Ashish Kamble; Muzammil Ahmad; Musti V Krishnasastry; Arvind Sahu
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.

Authors:  Viveka Nand Yadav; Kalyani Pyaram; Jayati Mullick; Arvind Sahu
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  Ethical and philosophical consideration of the dual-use dilemma in the biological sciences.

Authors:  Seumas Miller; Michael J Selgelid
Journal:  Sci Eng Ethics       Date:  2007-12-01       Impact factor: 3.525

9.  Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.

Authors:  Akhilesh K Singh; Viveka Nand Yadav; Kalyani Pyaram; Jayati Mullick; Arvind Sahu
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

10.  WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection.

Authors:  R Alvarez; J Reading; D F L King; M Hayes; P Easterbrook; F Farzaneh; S Ressler; F Yang; D Rowley; A Vyakarnam
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.